DZ712A1 - Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires. - Google Patents

Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires.

Info

Publication number
DZ712A1
DZ712A1 DZ847346A DZ847346A DZ712A1 DZ 712 A1 DZ712 A1 DZ 712A1 DZ 847346 A DZ847346 A DZ 847346A DZ 847346 A DZ847346 A DZ 847346A DZ 712 A1 DZ712 A1 DZ 712A1
Authority
DZ
Algeria
Prior art keywords
intermediates
preparation
derivatives
medicines
processes
Prior art date
Application number
DZ847346A
Other languages
English (en)
French (fr)
Original Assignee
Jenssen Pharmaceutica N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenssen Pharmaceutica N V filed Critical Jenssen Pharmaceutica N V
Application granted granted Critical
Publication of DZ712A1 publication Critical patent/DZ712A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ847346A 1983-12-05 1984-12-02 Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires. DZ712A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05

Publications (1)

Publication Number Publication Date
DZ712A1 true DZ712A1 (fr) 2004-09-13

Family

ID=24228139

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ847346A DZ712A1 (fr) 1983-12-05 1984-12-02 Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires.

Country Status (32)

Country Link
EP (1) EP0145067B1 (de)
JP (1) JPS60132977A (de)
KR (1) KR870000923B1 (de)
AR (1) AR241414A1 (de)
AT (1) ATE40361T1 (de)
AU (1) AU573658B2 (de)
BG (1) BG43866A3 (de)
CA (1) CA1337429C (de)
CS (1) CS250242B2 (de)
CY (1) CY1609A (de)
DD (1) DD235453A5 (de)
DE (1) DE3476388D1 (de)
DK (2) DK165112C (de)
DZ (1) DZ712A1 (de)
ES (1) ES538256A0 (de)
FI (1) FI82460C (de)
GR (1) GR81098B (de)
HK (1) HK52791A (de)
HU (1) HU202219B (de)
IE (1) IE57831B1 (de)
IL (1) IL73706A (de)
MA (1) MA20292A1 (de)
NO (2) NO169839C (de)
NZ (1) NZ210388A (de)
PH (1) PH22432A (de)
PL (1) PL146342B1 (de)
PT (1) PT79609B (de)
RO (1) RO91184B (de)
SG (1) SG47091G (de)
SU (1) SU1428199A3 (de)
ZA (1) ZA849445B (de)
ZW (1) ZW19784A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02103116U (de) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd ６―フルオロクロモン―２―カルボン酸及びその製造法
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
KR20010033188A (ko) * 1997-12-19 2001-04-25 조지 제이. 리코스 베타 3 아드레날린성수용체 작용물질로 유용한 카복실치환된 크로만 유도체
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
JP2004538289A (ja) 2001-07-26 2004-12-24 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ２−［５−（４−フルオロフェニル）−３−ピリジルメチルアミノメチル］−クロマンおよびその生理学的に許容し得る塩の新規な使用
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
ES2341250T3 (es) * 2004-08-11 2010-06-17 Hetero Drugs Limited Procedimiento novedoso de preparacion de intermediarios de nebivolol.
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
JP2008528626A (ja) 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． ヒドロキシル化されたネビボロールを含む薬学的組成物
WO2006084684A1 (de) * 2005-02-11 2006-08-17 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (de) * 2005-12-28 2012-07-25 Acino Pharma AG Ein Verfahren zur Herstellung von racemischem Nebivolol
EP1973895A1 (de) 2006-01-18 2008-10-01 Hetero Drugs Limited Verfahren zur isolierung gewünschter isomere von nebivolol-zwischenprodukten
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
ATE473224T1 (de) 2006-11-27 2010-07-15 Zach System Spa Verfahren zur herstellung von nebivolol
US20100137424A1 (en) 2007-01-22 2010-06-03 Mostafa Akbarieh Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) * 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
EP2907810A1 (de) 2014-02-14 2015-08-19 Corden Pharma International GmbH Neues Verfahren zur Herstellung von hochreinem Nebivolol-Hydrochlorid
PT2907809T (pt) 2014-02-14 2019-01-16 Corden Pharma Int Gmbh Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
CN113563295A (zh) 2015-05-19 2021-10-29 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (de) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
CA1337429C (en) 1995-10-24
ZW19784A1 (en) 1986-07-02
IL73706A0 (en) 1985-03-31
FI82460B (fi) 1990-11-30
HU202219B (en) 1991-02-28
EP0145067B1 (de) 1989-01-25
PL146342B1 (en) 1989-01-31
NO169839B (no) 1992-05-04
NO2004007I1 (no) 2004-12-20
DE3476388D1 (en) 1989-03-02
DD235453A5 (de) 1986-05-07
NO844845L (no) 1985-06-06
DK165112C (da) 1993-03-01
SG47091G (en) 1991-07-26
SU1428199A3 (ru) 1988-09-30
DK11892D0 (da) 1992-01-31
IE57831B1 (en) 1993-04-21
PL250524A1 (en) 1986-02-25
CY1609A (en) 1992-04-03
RO91184A (ro) 1987-07-30
DK165112B (da) 1992-10-12
KR870000923B1 (ko) 1987-05-07
EP0145067A3 (en) 1986-03-26
NO2004007I2 (no) 2005-05-09
RO91184B (ro) 1987-07-31
DK165321C (da) 1993-03-29
KR850004485A (ko) 1985-07-15
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
CS250242B2 (en) 1987-04-16
FI844777A0 (fi) 1984-12-04
IL73706A (en) 1988-07-31
DK577084D0 (da) 1984-12-04
FI82460C (fi) 1991-03-11
ES8603870A1 (es) 1986-01-01
IE843103L (en) 1985-06-05
PT79609B (en) 1986-12-12
DK165321B (da) 1992-11-09
DK11892A (da) 1992-01-31
ZA849445B (en) 1986-07-30
MA20292A1 (fr) 1985-07-01
NO169839C (no) 1992-08-12
PT79609A (en) 1985-01-01
EP0145067A2 (de) 1985-06-19
BG43866A3 (en) 1988-08-15
PH22432A (en) 1988-09-12
AU573658B2 (en) 1988-06-16
ES538256A0 (es) 1986-01-01
JPS60132977A (ja) 1985-07-16
AR241414A1 (es) 1992-07-31
HK52791A (en) 1991-07-19
FI844777L (fi) 1985-06-06
HUT37418A (en) 1985-12-28
JPH0250114B2 (de) 1990-11-01
NZ210388A (en) 1987-07-31
DK577084A (da) 1985-06-06
GR81098B (en) 1984-12-17

Similar Documents

Publication Publication Date Title
DZ712A1 (fr) Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires.
OA07097A (fr) Nouveaux dérivés d'arylphényléther utiles comme microbicides, procédé pour leur préparation et leur utilisation.
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
DZ418A1 (fr) Dérivés de céphalosporine, leur procédé de préparation et leur application thérapeutique.
FR2611366B1 (fr) Nouvelles cetones tricycliques utiles comme medicaments, procede et intermediaires pour leur preparation
OA07766A (fr) Procédé de préparation de dérivés de cephème.
OA07003A (fr) Préparation de nouveaux dérivés de la furo-(3,4-c) -pyridine.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA05630A (fr) Nouveaux dérivés phénoxybenzyloxycarbonyliques substitués, leur procédé de préparation et leur application comme insecticides et acaricides.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
OA07236A (fr) Dérivés de la triazine, procédés pour leur préparation, et compositions pharmaceutiques comportant ces dérivés.
OA07985A (fr) Nouveaux dérivés céphem, procédé pour la préparation de ces nouveaux composés compositions pharmaceutiques contenant au moins un de ces composés et intermédiaires de synthèse pour leur préparation.
OA06651A (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation, les compositions pharmaceutiques les renfermant.
MA21348A1 (fr) Procede pour la preparation de nouveaux derives aminoalcoxyphenyle.
DZ1946A1 (fr) Procédé pour la préparation de supports.
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
OA07674A (fr) Procédé de préparation de dérivés de carbapénem, nouveaux intermédiaires de synthèse et préparation de ces intermédiaires.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
MA21130A1 (fr) Procede de preparation de nouveaux aminopropionamides .
OA09140A (fr) Procédé de préparation de précurseurs des 3-acyl-2-oxindole-1-carboxamides anti-inflammatoires.
OA07833A (fr) Procédé de préparation de nouveaux dérivés de 1-(acétylamino)-2-amino-propanone.